T. Rowe Price Investment Management’s Alignment Healthcare ALHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ALHC
HRCM
T. Rowe Price Investment Management's ALHC Position: Q2 2026 in Review
T. Rowe Price Investment Management reduced its Alignment Healthcare (ALHC) stake by 0.21% in Q2 2026, selling an estimated $539K and leaving 13,119,557 shares worth $312M. The position accounts for 0.2% of the portfolio, ranked #132.
T. Rowe Price Investment Management first reported a position in ALHC in Q3 2022 and has held it in 16 quarters since. 322 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.
- T. Rowe Price Investment Management held 13,119,557 shares of Alignment Healthcare worth $312M as of Q2 2026.
- T. Rowe Price Investment Management sold 28,099 Alignment Healthcare shares in Q2 2026, an estimated $539K.
- Alignment Healthcare made up 0.2% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #132 holding.
- T. Rowe Price Investment Management first reported a position in Alignment Healthcare in Q3 2022 and has held it in 16 quarters since.
- 322 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.
Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.